ALG11-CDG (CDG-Ip)
Alternate names[edit | edit source]
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P ; CDG syndrome type Ip; CDG-Ip; Carbohydrate deficient glycoprotein syndrome type Ip; Congenital disorder of glycosylation type 1p; ALG11-CDG; Congenital disorder of glycosylation type Ip
Summary[edit | edit source]
A form of congenital disorders of N-linked glycosylation characterized by facial dysmorphism (microcephaly, high forehead, low posterior hairline, strabismus), hypotonia, failure to thrive, intractable seizures, developmental delay, persistent vomiting and gastric bleeding. Additional features that may be observed include fat pads anomalies, inverted nipples, and body temperature oscillation.
Cause[edit | edit source]
The disease is caused by mutations in the gene ALG11 (13q14.3).
NIH genetic and rare disease info[edit source]
ALG11-CDG (CDG-Ip) is a rare disease.
| ALG11-CDG (CDG-Ip) Resources | ||
|---|---|---|
|
| |
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Deepika vegiraju, Prab R. Tumpati, MD
